Bristol Myers Earnings Are a ‘Tale of 2 Trends’ as Guidance Falls Short. The Stock Is Falling
Drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a share-price ...
Bristol Myers Earnings Are ‘a Tale of 2 Trends’ as Guidance Falls Short
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...
Zacks.com on MSN1d
4 Semiconductor Stocks to Buy on Solid Rebound in Sales
The semiconductor market made a solid rebound last year after suffering for most of 2022 and 2023. Higher demand from a variety of industries coupled with the ongoing enthusiasm surrounding artificial ...
stocknews2d
3 Beaten-Down Tech Stocks Poised for a Major Comeback
The technology sector is well-positioned for significant growth due to AI, cloud computing, and cybersecurity advancements.